Objective Platinum nanoparticles (nano-Pt) have been reported to possess anti-oxidant and anti-tumor activities. However, the biological activity and mechanism of action of nano-Pt in inflammation are still unknown. The present study was designed to determine the in-vitro anti-inflammatory effects of nano-Pt on lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. Methods RAW 264.7 macrophages were used for the study. The LPS-induced production of reactive oxygen species (ROS) was determined by flow cytometry. The prostaglandin E 2 (PGE 2 ) concentration was measured using a PGE 2 assay kit. The protein levels and mRNA expression of the pro-inflammatory cytokines [tumor necrosis factor-a, interleukin (IL)-1b and IL-6], along with cyclooxygenase (COX-2) and inducible nitric oxide synthase, were analyzed by Western blotting and reverse transcription-polymerase chain reaction analysis. The phosphorylation of extracellular signal regulated kinase (ERK1/2) and Akt, and the phosphorylation and degradation of inhibitory kappa B-alpha (IjB-a) was determined by Western blot analysis. Results Nano-Pt significantly reduced the LPS-induced production of intracellular ROS and inflammatory mediators. In addition, nano-Pt suppressed the phosphorylation of ERK1/2 and Akt, and significantly inhibited the phosphorylation/degradation of IjB-a as well as nuclear factor kappa-B (NFjB) transcriptional activity. Conclusion These results suggest that the anti-inflammatory properties of nano-Pt may be attributed to their downregulation of the NFjB signaling pathway in macrophages, thus supporting the use of nano-Pt as an antiinflammatory agent.
Introduction
Inflammation is one of the most crucial aspects of the host defense against invading pathogens. Aberrant regulation of inflammation has been considered to be one of the major causes of human cancer [1] . Factors involved in the inflammatory process include physical and chemical stimulants that are released during the immune response, and by tissue necrosis. Nitric oxide (NO) and reactive oxygen species (ROS) play a significant role in the inflammatory response. During an inflammatory response, the excessive production of ROS can cause major damage to cells, which can lead to DNA damage and mutations [2, 3] .
Macrophages are the primary pro-inflammatory cells that provide the first line of defense against these harmful stimuli. In response to extracellular stimuli such as ultraviolet (UV) irradiation or lipopolysaccharide (LPS) stimulation, macrophages mediate the inflammatory response by releasing a variety of pro-inflammatory mediators, such as tumor necrosis factor (TNF)-a, interleukin (IL)-1b, IL-6 and prostaglandin E 2 (PGE 2 ), which exert profound effects on endothelial, epithelial and mesenchymal cells in the local microenvironment [4, 5] . The overproduction of these pro-inflammatory mediators results in aggravated inflammatory responses [6] .
Nuclear factor-jB (NFjB) is one of the key regulators of pro-inflammatory gene expression. In unstimulated cells, NFjB is retained in the cytoplasm by binding with a family of inhibitory proteins, the inhibitors of NFjB (IjB). Upon cell stimulation, the phosphorylation and degradation of IjB-a leads to the translocation of free NFjB to the nucleus [7, 8] . Anomalous activation of NFjB is a clinical hallmark of chronic inflammation, and is associated with many types of cancer. Compounds having NFjB inhibitory activity have therefore been found to be useful additions to the chemotherapy regimens for a variety of inflammatory disorders and cancer [9, 10] .
Nanotechnology is becoming increasingly important for research on the development of new therapeutic approaches for cancer, inflammation and aging. Nanoparticles are currently being applied not only in material science and engineering, but also in medical science and for clinical use. Nanoparticles can be antioxidants, thus reducing the production of ROS in the body. Polyacrylic acid-protected platinum nanoparticles (nano-Pt) are manufactured by reduction with ethanol for 2 h [11] . Platinum-based compounds gained attention after the discovery of the antitumor activity of cis-diamminedichloroplatinum [12] . Recently, we have demonstrated that nano-Pt can exert superoxide dismutase (SOD) catalase mimetic activity, which could be useful in the prevention of a number of oxidative stress-associated pathologies, such as inflammatory reactions and cellular transformation [13] .
In the present study, we examined the mechanism of action involved in the anti-inflammatory effects of nano-Pt on RAW 264.7 macrophage cells stimulated by LPS. The results of the current study clearly indicate that nano-Pt have anti-inflammatory effects, and these effects appear to be mediated, at least partly, by the inhibition of NFjB signaling.
Materials and methods

Materials
Nano-Pt were prepared by a described previously method [11] . The Isogen RNA extraction kit was obtained from Nippon Gene (Tokyo, Japan). M-MLV reverse transcriptase was from GIBCO (Grand Island, NY, USA). Taq DNA polymerase was purchased from Perkin-Elmer (Norwalk, CO, USA). The LPS was purchased from Sigma (St. Louis). The anticyclooxygenase-2 (COX-2) polyclonal antibody (pAb) was purchased from Cell Signaling Technology, Inc. (Boston, MA, USA), the anti-inducible nitric oxide synthase (iNOS) pAb from Enzo Life Sciences International Inc. (NY, USA), and the anti-b-actin Ab from Santa Cruz Biotechnology Inc. (CA, USA). The Western blot detection system was obtained from Cell Signaling Technology (Beverly, MA, USA). All other reagents were of analytical grade.
Preparation of nano-Pt
Nano-Pt were prepared by the citrate reduction of H 2 PtCl 6 , according to a previous report with minor modifications [11] . Briefly, 43.8 ml H 2 O was poured into a 100 ml eggplant-type flask and 4 ml of 16.6 mM H 2 PtCl 6 was added. The reaction mixture in the flask was stirred at 100°C until reflux started. An 8.6 ml aliquot of 77.2 mM trisodium citrate dihydrate was injected into the reaction mixture and reflux was continued for additional 30 min. A change in the color of the reaction mixture from light yellow to dark brown or dark red was observed, thus indicating the start of platinum reduction and nanoparticle formation. The reaction mixture was cooled to room temperature, 10 ml of 3.96 mg/ml pectin was added and the mixture was stirred for 1 h. More pectin was added to improve the stability of the nano-Pt. Finally, the average diameter of the nano-Pt was determined to be 2.4 ± 0.7 nm. The micro-molar concentration refers to the molarity of the platinum. The original molarity of platinum was 1 mM. Therefore, 100 ll from the 1 mM solution was diluted into 1 ml of medium to make a 100 lM solution.
Cell culture RAW 264.7 cells (mouse) were obtained from the American Type Culture Collection (Manassas, VA, USA). Cultured cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10 % fetal bovine serum and 1 % antibiotics, at 37°C in humidified air with 5 % CO 2 .
MTT assay
The cells were seeded in 96-well plates (2.5 9 10 3 cells/ well) and grown in DMEM for 24 h. Nano-Pt (10, 50, 100, 500 and 1,000 lM) were added to the cells for 24 h. The medium was removed, and another medium containing 10 % MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) solution (Sigma, 0.5 mg/ml in PBS) was added to each well. The cells were incubated for 4 h at 37°C, the supernatants were removed, and dimethyl sulfoxide (Sigma) was added to each well. The optical density was measured at 570 nm using a Bio-Rad microplate reader (Hercules, CA, USA).
Assessment of intracellular ROS
The intracellular ROS levels were measured by flow cytometry using two different fluorescent probes with different affinities for ROS: hydroethidine (HE) was used to confirm the production of superoxide (O 2 -) while dichlorofluorescein diacetate (DCFH-DA) was used to evaluate the involvement of peroxides, including hydrogen peroxide (H 2 O 2 ). After a 10-min incubation following LPS treatment, cells were stained with 2 lM HE and 5 lM DCFH-DA, and incubated for 30 min at 37°C in the dark. Finally, cell samples were injected into a flow cytometer for the analysis. PGE 2 and cytokine assays RAW 264.7 cells were treated with nano-Pt at various concentrations (10, 50 or 100 lM), and stimulated with LPS (10 lg/ml). The 24-h culture media were collected, and the PGE 2 concentration was measured using a PGE 2 assay kit (R&D Systems, Minneapolis, MN, USA). The protein and mRNA expression levels of IL-1b, IL-6 and TNF-a were determined by a Western blot analysis and reverse transcription-polymerase chain reaction analysis (RT-PCR).
Western blot analysis
Cells were collected and washed with cold PBS. The cells were lysed at a density of 1 9 10 6 cells/50 ll of RIPA buffer [1 M Tris-HCA, 5 M NaCl, 1 % Nonidet P-40 (v/v), 1 % sodium deoxycholate, 0.05 % SDS, 1 mM phenylmethyl sulfonyl fluoride] for 20 min. After brief sonication, the lysates were centrifuged at 12,000 rpm for 10 min at 4°C, and the protein content in the supernatants was measured using a Bio-Rad protein assay kit. The protein lysates were denatured at 96°C for 5 min after mixing with 5 ll of sodium dodecylsulfate (SDS) loading buffer, applied on an SDS polyacrylamide gel for electrophoresis, and transferred to nitrocellulose membranes. Western blot analysis was carried out to detect the expression levels of COX-2, iNOS, IL-6, IL-1b, TNF-a, IjB-a, p-IjB-a, Akt, p-Akt, ERK1/2, p-ERK1/2, p38, p-p38, SAPK/JNK and p-SAPK/JNK using specific antibodies. Band signals were visualized on X-ray film using chemiluminescence ECL detection reagents (Amersham Biosciences, Buckinghamshire, UK). The relative amounts of proteins associated with specific antibodies were normalized to the intensities of b-actin. Band density was quantified by a BIO-ID image analyzer, and the relative amounts of proteins associated with specific antibodies were normalized to the intensities of b-actin.
Reverse transcription-polymerase chain reaction analysis
Total RNA was extracted and RNA reverse transcription was performed with M-MLV reverse transcriptase using random hexamer primers, and subsequent amplification was done using Taq DNA polymerase. PCR was carried out for 30 cycles with denaturation at 94°C for 30 s, annealing from 52 to 64°C for 1 min and extension at 72°C for 30 s using a thermal cycler (PE Applied Biosystems Gene Amp PCR system 9700). The IL-6 primers used were 5 0 -GATGCAAT AACCACCCCTGACCC-3 0 (forward) and 5 0 -CAATCTGA GGTGCCCATGCTAC-3 0 (reverse). The TNF-a primers used were 5 0 -ACACCGTCAGCCGATTTGC-3 0 (forward) and 5 0 -CCCTGAGCCATAATCCCCTT-3 0 (reverse). The iNOS primers used were 5 0 -TCC TACACCACACCAAA C-3 0 (forward) and 5 0 -CTCCAATCTCTGCCTATCC-3 0 (reverse). The COX-2 primers used were 5 0 -CTTCACGCA TCAGTTTTTCAAG-3 0 (forward) and 5 0 -TCACCGTAAAT ATGATTTAAGTCCAC-3 0 (reverse). The IL-1b primers used were 5 0 -TCAAGGCATAACAGGCTCATC-3 0 (forward) and 5 0 -CCACGGGCAAGACATAGGTAG-3 0 (reverse) [14] . GAPDH was used as a positive control; the primers used were 5 0 -ACCCAGAAGACTGTGGAT-3 0 (forward) and 5 0 -TCGTTGAGGGCAATGCCA-3 0 (reverse). After PCR, the amplified products were analyzed using 2 % agarose gel electrophoresis.
Statistical analysis
Differences between the various treatments were statistically analyzed using Student's t test. For comparisons of multiple groups, one-way ANOVA was applied to the data. p \ 0.05 were considered statistically significant. Data in the figures are shown as the mean ± SD of several experiments.
Results
Cytotoxicity of nano-Pt on RAW 264.7 cells
Cell viability before treatment was always over 95 %, as evaluated by the Trypan blue dye exclusion test (data not shown). The cytotoxic effects of nano-Pt (10, 50, 100, 500 and 1,000 lM) were evaluated in RAW 264.7 cells, which found that Nano-Pt exert no cytotoxic effects on RAW 264.7 cells even at a concentration of 1,000 lM (Fig. 1) .
Nano-Pt inhibit intracellular ROS production in LPSstimulated RAW 264.7 cells
We first examined the effects of nano-Pt on LPS-induced ROS production in RAW 264.7 cells. The RAW 264.7 cells were treated with LPS at concentrations of 1 and 10 lg/ml for different time intervals, and flow cytometry with HE and DCFH-DA staining was used to detect the ROS production in the cells. A marked increase in the production of O 2 -and H 2 O 2 was observed after 10 min of LPS stimulation at the concentration of 10 lg/ml (Fig. 2a) . Furthermore, a 24 h pre-incubation with 100 lM nano-Pt significantly inhibited the LPS-induced production of intracellular ROS (Fig. 2b) . Accordingly, we used a 10 lg/ ml concentration of LPS for the next series of experiments.
Nano-Pt reduce the protein and mRNA expression levels of iNOS in LPS-stimulated RAW 264.7 cells
To examine the anti-inflammatory activity of nano-Pt, we examined the effects of nano-Pt on the iNOS mRNA and protein expression in the LPS-stimulated macrophages. LPS stimulation of the RAW 264.7 cells strongly upregulated the iNOS protein and mRNA expression levels. As shown in Fig. 3a and b, treatment with nano-Pt (10-100 lL) caused a significant decrease in the protein and mRNA levels of iNOS in a dose-dependent manner.
Previously, it was reported that the overproduction of NO is regulated by iNOS, and that it is involved in the pathogenesis of several inflammatory diseases [15] . Therefore, on the basis of these results, we speculated that the nano-Pt attenuate the production of NO by reducing the expression of iNOS in LPS-stimulated murine macrophages. Nano-Pt reduce PGE 2 production and the levels of COX-2 protein and mRNA expression in RAW 264.7 cells
In order to assess the anti-inflammatory properties of nanoPt, the inhibitory effects of nano-Pt on the LPS-induced production of PGE 2 were investigated in the RAW 264.7 cells. LPS stimulation resulted in the increased production of PGE 2 by up to tenfold compared to unstimulated cells, but nano-Pt (10-100 lL) successfully attenuated the increased PGE 2 production in a dose-dependent fashion (Fig. 4a) . Furthermore, to investigate a potential mechanism involved in the inhibition of PGE 2 , we examined the effects of nano-Pt on the protein and mRNA expression of the COX-2 enzyme. As shown in Fig. 4b , the band density of COX-2 is reduced compared to b-actin, this finding indicating that 100 lL of nano-Pt significantly reduced the protein expression of the COX-2 enzyme. The COX-2 mRNA expression was also significantly decreased in a dose-dependent manner (Fig. 4c) . The above findings indicate that the inhibition of PGE 2 occurs via the suppression of COX-2 expression. Nano-Pt reduce the release of pro-inflammatory cytokines by LPS-stimulated RAW 264.7 cells LPS stimulation of RAW 264.7 cells increased their production of pro-inflammatory cytokines, including IL-6, IL-1b and TNF-a. After treatment with nano-Pt, these increases were significantly reduced in a dose-dependent manner, as shown in Fig. 5a . These results were further confirmed by comparing the differences in the band densities of these cytokines to b-actin using the BIO-ID image analyzer. In addition, nano-Pt also caused a reduction in the LPS-induced mRNA levels of IL-6, IL-b and TNF-a (Fig. 5b) .
Nano-Pt inhibit NFjB signaling and IjB-a degradation in LPS-stimulated RAW 264.7 cells
In the LPS-stimulated RAW 264.7 cells, the activation of NFjB leads to the increased transcription of pro-inflammatory mediators, such as iNOS, COX-2, TNF-a, IL-6 and IL-1b. To investigate the phenomena involved in the inhibition of the NFjB transcriptional activity, the effects of nano-Pt on the degradation of IjB-a were studied. We observed that nano-Pt blocked the degradation of IjB-a (Fig. 6 ), suggesting that it significantly attenuates the LPS-stimulated translocation of NFjB by blocking IjB-a degradation in RAW 264.7 cells.
Nano-Pt inhibit the phosphorylation of Akt and ERK1/2 in LPS-stimulated RAW 264.7 cells RAW 264.7 cells were stimulated with LPS for 20 min, resulting in the activation of Akt and the MAPK proteins ERK1/2, p38 MAPK, and SAPK/JNK. The treatment of cells with nano-Pt (10-100 lL) for 1 h significantly inhibited the LPS-induced phosphorylation of Akt and ERK1/2. On the other hand, we found that nano-Pt had no inhibitory effect on the phosphorylation of p38 and SAPK/ JNK in mouse macrophages (Fig. 7) .
Discussion
In this study, we demonstrated that LPS stimulation of RAW 264.7 cells enhanced their accumulation of intracellular ROS. NO and ROS are known to be crucial inflammatory mediators. ROS accumulation is an important factor in the pathogenesis of many diseases, including inflammation and cancer [16] . ROS are also considered to be implicated in the expression of inflammatory genes via the redox-based activation of the NFjB signaling pathway [17] . Pretreatment of cells with nano-Pt significantly reduced the LPS-induced ROS production. We previously reported that nano-Pt effectively protect against UV-induced inflammation by decreasing ROS production [18] . Nano-Pt are known to possess strong antioxidant activity and are capable of scavenging ROS [11] . A recent study also demonstrated that nano-Pt significantly inhibited RANKL-stimulated osteoclastogenesis in RAW 264.7 cells by the suppression of ROS [19] . Overproduction of NO is regulated by iNOS, and is involved in the pathogenesis of several inflammatory diseases [15] . In the present study, Nano-Pt were also found to reduce the expression of iNOS mRNA and protein, demonstrating that nano-Pt effectively inhibit NO production via the downregulation of iNOS expression. Cisplatin is a platinum-based type of chemotherapy and is one of the cytotoxic agents commonly used in cancer chemotherapy. Cisplatin exerts its activity by interfering with transcription and other DNA-mediated cellular functions [20] . Recently, it was reported that nano-Pt have anti-tumor activity, affecting DNA integrity [21] . The antitumor activity of nano-Pt may be due to the lethal DNA damage effects caused by soluble Pt ion species, resulting in DNA strand breaks and formation of Pt-DNA complexes [22] . In contrast, the inhibitory effects of nano-Pt on LPS-induced ROS were observed in the current study. Our results are consistent with the previous report, which showed that various sizes of nano-Pt (\20, \100, [100 nm) exert no influence on proliferation or growth inhibitory effects [22] , indicating that nano-Pt do not exhibit any serious cytotoxicity.
Nano-Pt reduced PGE 2 production induced by LPS in a dose-dependent manner. The Western blot analysis and RT-PCR assay showed that nano-Pt also inhibit the protein and mRNA expression of COX-2. These results indicate that nano-Pt significantly attenuated PGE 2 production via the inhibition of COX-2 mRNA and protein, thus suggesting that the specific inhibition of iNOS and COX-2 might be responsible for the anti-inflammatory activity of nano-Pt. Activated macrophages release pro-inflammatory cytokines, such as IL-1b, IL-6 and TNF-a. TNF-a promotes the induction of IL-6 and IL-1b; high levels of these cytokines can enhance malignancy and cause systemic complications [4, 23] . Nano-Pt suppressed the release of TNF-a, IL-6 and IL-1b in LPS-stimulated macrophages, showing that nano-Pt can attenuate the production of proinflammatory cytokines.
We also found that nano-Pt inhibited the LPS-induced phosphorylation of ERK1/2 and the phosphorylation/ degradation of IjB-a in a dose-dependent manner, which suggested that nano-Pt can inhibit NFjB activation by hampering the phosphorylation of ERK1/2 and subsequent phosphorylation/degradation of IjB-a in LPS-stimulated RAW 264.7 cells. Furthermore, LPS stimulation of mouse macrophages induces the phosphorylation of Akt; previous studies have shown that the activation of the Akt signaling Fig. 4 The effects of nano-Pt on the LPS-induced production of PGE 2 and the expression of COX-2 in RAW 264.7 cells. Nano-Pt decreased PGE 2 production and COX-2 expression in LPS-stimulated RAW 264.7 cells. The cells were pretreated with various concentrations of nano-Pt (10, 50 or 100 lM), then stimulated with LPS (10 lg/ml). a The 24 h culture media were collected to measure the PGE 2 concentration. Each bar represents the mean ± SD (n = 5), *p \ 0.001. b Cell lysates were subjected to Western blot analysis with an anti-COX-2 antibody or an anti-b-actin antibody. b-Actin was used as an internal control for the Western blot analysis, iNOS signals were normalized to the b-actin signals, and the relative ratios are shown above each band. c The total RNA was isolated, and the mRNA expression of COX-2 in cells was detected by RT-PCR, using human GADPH as an internal control for the RT-PCR. Representative results from three independent experiments are shown pathway enhances the degradation of IjB-a and leads to the activation of NFjB [24] . The LPS-induced phosphorylation of Akt was also inhibited by nano-Pt.
In our search for the mechanism(s) underlying the antiinflammatory effects of nano-Pt, we focused on two distinct signaling pathways, the NFjB and MAPK pathways. In response to extracellular stimuli, MAPKs can be activated and can cause consecutive phosphorylation of several important signaling molecules that regulate cell growth, inflammation and apoptosis [25, 26] . Several previous reports have documented that the specific MAPK inhibitors also inhibit NFjB transcriptional activity, demonstrating that MAPKs are crucial factors for the activation of NFjB [27, 28] . Activated NFjB acts as a transcription factor, leading to increased expression of several inflammatory genes, such as iNOS, TNF-a, COX-2, IL-1b and IL-6 [29] . Taken together, our findings revealed that the anti-inflammatory effects of nano-Pt might be attributable to the suppression of Akt and ERK activation and the subsequent inhibition of NFjB, thus resulting in the reduced expression of iNOS and COX-2, and inhibition of ROS and inflammatory cytokines.
In conclusion, the current study provides a description of at least one molecular mechanism involved in the antiinflammatory effects of nano-Pt on macrophages. The anti-inflammatory effects of nano-Pt were attributed to the suppression of Akt and ERK phosphorylation and the subsequent inhibition of NFjB (Fig. 8) , suggesting that nano-Pt could be used as an effective inflammatory agent. 
